ARCHIVES

In Congress: Societies, Advocates, Testify For Increases In Research Funding

This article is from The Cancer Letter archive.

Vol. 24 No. 06 | February 13, 1998

Download PDF Visit The Full Archive

Related Articles

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010

Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials.

December 2, 2005

Proflavine Bioassay Ineffective, NCI Says

July 15, 1977

Hammer Says President’s Science Advisory to Ask For FY 1985 Supplemental Appropriations for NCI

March 1, 1985

AACI Committee Makes Case For Clinical Research In Centers; Cancer Control, Group Funds Eyed

December 8, 1978

Lasagna Committee Urges Medicare Payment for Experimental Drugs, Care

September 29, 1989